ECG Telemetry Devices Market Report by Product (Event Monitoring and MCT (Mobile Cardiac Telemetry), and Others), Application (Arrhythmias, Myocardial Ischemia and Infarction, Pacemaker Monitoring, and Others), End User (Hospitals, Home Healthcare), and R

ECG Telemetry Devices Market Report by Product (Event Monitoring and MCT (Mobile Cardiac Telemetry), and Others), Application (Arrhythmias, Myocardial Ischemia and Infarction, Pacemaker Monitoring, and Others), End User (Hospitals, Home Healthcare), and Region 2024-2032


The global ECG telemetry devices market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.22% during 2024-2032.

Electrocardiography (ECG) telemetry devices enable rapid ECG monitoring of patients with suspected cardiovascular diseases (CVDs). They help detect electrical impulses generated by cardiac tissues, which are subsequently translated into waveforms. They find extensive applications in hospitals and home healthcare services. At present, the increasing prevalence of CVDs, such as heart attacks and strokes, due to alcohol and tobacco consumption, obesity, and physical inactivity among individuals is catalyzing the demand for ECG telemetry devices across the globe.

ECG Telemetry Devices Market Trends:
ECG telemetry devices are used in the diagnosis and treatment of arrhythmia wherein the heart rate of an individual becomes abnormal. These devices offer information about fluctuations in the rhythm of the heart that allows doctors to take required actions. Apart from this, ECG telemetry devices comprise resting ECGs, which are utilized for identifying conditions, such as coronary artery disease (CAD) or congestive heart failure (CHF). This, along with the thriving healthcare industry, is strengthening the growth of the market. Besides this, there is a significant rise in the utilization of health monitoring devices like electrocardiographs, digital thermometers, automatic blood pressure monitors, blood glucose monitors, and body fat monitors in the residential sector. They can be operated by patients or their caretakers with minimal training. Furthermore, coronavirus disease (COVID-19) affects the cardiovascular system and leads to myocardial damage and cardiac and endothelial dysfunction. This, coupled with the increasing geriatric population, is propelling the demand for ECG telemetry devices around the world. Other factors, including rising technological advancements and the growing awareness about cardiovascular health among the masses, are projected to influencing the overall sales and profitability positively in the coming years.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global ECG telemetry devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application, and end user.

Breakup by Product:

Event Monitoring and MCT (Mobile Cardiac Telemetry)
Others

Breakup by Application:

Arrhythmias
Myocardial Ischemia and Infarction
Pacemaker Monitoring
Others

Breakup by End User:

Hospitals
Home Healthcare

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and ZOLL Medical Corporation (Asahi Kasei Corporation).

Key Questions Answered in This Report

1. What was the size of the global ECG telemetry devices market in 2023?
2. What is the expected growth rate of the global ECG telemetry devices market during 2024-2032?
3. What has been the impact of COVID-19 on the global ECG telemetry devices market?
4. What are the key factors driving the global ECG telemetry devices market?
5. What is the breakup of the global ECG telemetry devices market based on the product?
6. What is the breakup of the global ECG telemetry devices market based on the application?
7. What are the key regions in the global ECG telemetry devices market?
8. Who are the key players/companies in the global ECG telemetry devices market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global ECG Telemetry Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Event Monitoring and MCT (Mobile Cardiac Telemetry)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Others
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Arrhythmias
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Myocardial Ischemia and Infarction
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Pacemaker Monitoring
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Home Healthcare
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Aerotel Medical Systems (1998) Ltd.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Compumed Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Hill-Rom Holdings Inc. (Baxter International Inc.)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 iRhythm Technologies Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Koninklijke Philips N.V.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Medicalgorithmics S.A.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Medtronic plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Nihon Kohden Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Preventice Solutions Inc. (Boston Scientific Corporation)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 ScottCare Cardiovascular Solutions
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 ZOLL Medical Corporation (Asahi Kasei Corporation)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings